Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)

Market Cap	14.22B +24.9%
Revenue (ttm)	2.42B +3.3%
Net Income	646.23M +11.0%
EPS	1.19 +8.3%
Shares Out	569.44M
PE Ratio	21.00
Forward PE	n/a
Dividend	0.44 (1.76%)
Ex-Dividend Date	Sep 22, 2025

Volume	4,638,137
Average Volume	5,501,454
Open	24.70
Previous Close	24.96
Day's Range	24.40 - 24.98
52-Week Range	20.27 - 38.16
Beta	0.20
RSI	54.24
Earnings Date	Apr 24, 2026

About SHE:002287

Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China and internationally. The company also provides plasters, topical and oral tibetan medicines, and ointments. Its products are used in areas of orthopedics, neurology, dermatology, granules, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, musculoskeletal system, nervous system, respiratory, digestive, urinary, and cerebrovascular sectors. The company was founded in 1995 and is based in Nyingchi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 3,170
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002287

Financial Performance

In 2025, SHE:002287's revenue was 2.42 billion, an increase of 3.34% compared to the previous year's 2.34 billion. Earnings were 646.23 million, an increase of 10.98%.